Cytos appoints new board member
This article was originally published in Scrip
Zurich, Switzerland-headquartered Cytos Biotechnology, a public biopharmaceutical company developing targeted immunotherapies, has named Dr Yamo Deniz to its board of directors. Dr Deniz is currently chief medical officer, global head of medical and pharmacovigilance at GE Healthcare Lifesciences. He is also a member of French firm DBV Technologies' corporate scientific advisory board.